The mechanisms of metabolism comprise a large number of biochemical pathways with a myriad of poorly characterised genetic influences. In this study, we perform a systematic integration of chromatin interaction (Hi-C), expression quantitative trait loci (eQTL), gene ontology, drug interaction, and literature-supported connections to deconvolute the genetic regulatory influences of 145 blood metabolite-associated single nucleotide polymorphisms (SNPs). We identify 577 genes that are regulated via chromatin looping to 130 distal and proximal SNPs across 48 different human tissues.
Introduction
The interaction between genetic variation, environment and lifestyle affects metabolite levels in humans 1 . The levels of these metabolites are central to the expression of phenotypes and disease development e.g. cholesterolaemia, cancer, and type 2 diabetes [2] [3] [4] . Despite decades of work targeting metabolites of interest, the genetic networks and genes that modify metabolic potential remain poorly characterised and their therapeutic and diagnostic utility remains unrealized.
Whole genome or exome sequencing, in combination with metabolomic techniques, have been used to identify the genetic influencers of the human blood metabolome [5] [6] [7] [8] [9] . In arguably the most comprehensive analysis to date, Shin and colleagues 5 performed a genome-wide association study (GWAS) and identified 145 genetic loci (SNPs) that correlate with the levels of approximately 400 blood metabolites. As is typical of all GWAS studies, >65% of the SNPs identified by Shin et al. were in noncoding regions of the genome. Shin et al. predicted causal genes of the genetic loci by scanning 500 kilobase (Kb) regions flanking the SNPs for genes whose functions linked with the corresponding metabolite. While it is commonly accepted that GWAS SNPs are enriched in regulatory elements, identifying the genes affected by the SNPs using a nearest-relevant-gene approach is problematic because the accumulating evidence supports long-range gene regulatory interactions, including interchromosomal, between regulatory elements and genes [10] [11] [12] [13] . Moreover, recent studies suggest that long-range regulatory interactions may play a more significant role in modifying disease outcomes than proximal interactions [14] [15] [16] . Long-range gene regulatory interactions can occur by several mechanisms: 1) epistatic interactions between gene products; 2) widespread action of a transcription factor or non-coding RNA; 3) scanning (e.g. the spreading of silencing complexes along a chromosome); or 4) chromatin looping (e.g. direct physical contact between enhancers and gene promoters) 17 . We, and others, have previously used genome structural data captured by proximity ligation techniques (e.g. Hi-C 18 ) and eQTL data (e.g. GTEx 19 ) to detect chromatin loops that bring long-range regulatory loci in spatial proximity with their target genes 14, [20] [21] [22] [23] [24] .
Here, we set out to use the 3D genome organization to identify target genes for the 145 blood metabolite-associated SNPs reported by Shin et al. 5 . To achieve this, we interrogated chromatin interaction (Hi-C) data from eight human cell lines 25 ( Supplementary Table 1 ) to identify genes that are in physical contact with the SNPs 24 .
Next, we designated functional SNP-gene associations by interrogating expression quantitative trait loci (eQTL) in 48 human tissues from the Genotype-Tissue Expression (GTEx 19 , www.gtexportal.org) database 24 Figure 1 ). Supplementary Table 4 ). Notably, the eSNPs were associated with between 1 and 23 eGenes, with 3 eGenes as the mode (Figure 1c ), in a tissue specific manner. This is consistent with previous reports on shared gene regulatory sites 24, 26, 27 . Altogether, we identified 2,757 eSNP-eGene interactions in 48 different human tissues (Supplementary Table 5 ) of which 621 overlapped Shin et al.'s predictions (effect size range, -1.69778 to 1.05834), while 2,136 are novel (effect size range, -1.15093 to 1.65858; Figure 1d ). annotated as being involved in ≥1 biochemical pathway (Supplementary Table 4 ). As expected, the largest single set of annotations for the eGenes is metabolism (n = 95, Figure 2a ). The next most represented categories i.e. organismal systems (n = 75) and human diseases (n = 65) each share 12 genes with the metabolism category ( Figure 2a ). Classification of the eGenes using The Human Protein Atlas identified significant enrichment (bootstrapping of null sets) of enzymes, plasma proteins, disease related genes and potential drug targets within 490 of the eGenes (Figure 2b , Supplementary Table 4 ). The observed enrichment in the metabolic pathway and protein classification analyses is consistent with the eGene products acting as modifiers of metabolic activity.
Results

Metabolite-associated SNPs mark eQTLs
We screened the Drug Gene Interaction database (DGIdb) to identify which of the eGenes encode potentially targetable products. Products of 147 (25.5%) of the eGenes are targets of at least one drug (Figure 2c , Supplementary Table 6 ). 68, 119, and 142 of the druggable eGenes are also involved with metabolism, >1 biochemical pathway, and >1 protein class respectively. 101 of the 147 druggable eGenes have not been previously linked to genetic variants associated with metabolism.
There were several notable examples of metabolite associated gene-eSNP networks.
For example, APOE, which has been associated with modulation of total cholesterol 34 [28] [29] [30] [31] supporting their links with cholesterol. b) ACSM5 pairs as an eGene with rs11647589, rs6497490, and rs1394678, which were associated with 3-phenylpropionate, X-11478 (an unknown metabolite), and indolepropionate respectively. The metabolism of 3-phenylpropionate and indolepropionate requires a Coenzyme A ligase such as ACSM5 32, 33 .
Literature text mining supports eGene-metabolite associations
We conducted a stringent semi-automated literature text mining to identify literature that supported a link between the eGenes and the metabolites with which the eSNPs are associated. Firstly, we queried the MEDLINE database using PubMed APIs for research article titles or abstracts that contain the eSNP-eGene, eSNP-metabolite, or eGene-metabolite pairs (Figure 4a ). We then manually curated articles supporting Table 7 ). 29 of the literature-supported associations include genes that are involved at least one biochemical pathway and whose products are druggable (Figure 4b and c).
The literature supported the putative functional outcomes for the rs445925-APOE, BCAM, RYR1, RERE network as follows: 1) BCAM had a suggestive association in a GWAS meta-analysis of LDL cholesterol response to statins 29 ; 2) RYRI, together with other nonalcoholic steatohepatitis related genes, has been linked to dietary cholesterol 30 ; and 3) RERE was associated with circulating blood CD34+, which positively relates to total cholesterol 31 . Therefore, we contend that these eQTL associations not only link SNPs to genes that are relevant to cholesterol, they also reveal the tissues that might be important for its metabolism.
The absence of literature support for eGene-metabolite associations does not equate to an absence of relationship. For example, the intergenic rs7809615 is associated with levels of androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 in the blood metabolite GWAS (Supplementary Table 2 ). Our method, as well as that of Shin et al., links rs7809615 to CYP3A5 (Figure 4c ), which encodes a cytochrome P450 known to be active against steroids such as testosterone 36 . rs7809615 also links with CYP3A7 (Figure 4c ), which encodes another P450. Although our stringent text mining did not find articles that directly link the two target eGenes, the STRING database (v10.5, accessed 26/04/2019) reports a binding interaction between CYP3A5 and CYP3A5. Supplementary Table 2 ) of the eSNPs that spatially interact with the eGenes. The red-colored numbers indicate that the relationship between an eGenes and its SNP-associated metabolite ( Supplementary Table 4 ) is supported in literature via text mining.
Discussion
We systematically integrated evidence from chromatin interactions, eQTL data, gene ontology, protein classifications, drug interactions, and the published literature to identify and characterize genes that are regulated by metabolite-associated SNPs.
Our results provide a step-change in our current understanding of the variant-gene regulatory interactions of metabolism, particularly those that rely on chromatin looping.
The integration of chromatin interaction and eQTL data in this study enabled the mapping of long-range regulatory interactions for ~90% of the metabolite-associated SNPs. This mapping was robust to the different data sources that were used to identify the eQTLs (GTEx 19 ) and the blood metabolite associated SNPs (KORA and Twins UK) 5 . The identification of associations between metabolite-associated eSNPs and eGenes in non-metabolism ontological classes, or with unknown functions provides novel data-driven avenues for empirical testing to delineate the roles played by these eGenes in metabolism. Similarly, the eSNP-eGene connections reported here for variants associated with unknown metabolites could aid the identification of unknown metabolites.
The limited literature support, identified by text mining, for the eGene-metabolite associations can be attributed to: a) the stringent condition that both terms must be mentioned in the title or summary of an article; b) the fact that the identity of the SNP associated metabolites was not always known; and c) indirect relationships between some eGene products and metabolites. That there is more literature support for eGene-metabolite relationships than for the eSNP-metabolite or eSNP-eGene associations highlights the utility of our approach in bridging the existing knowledge gap.
Our agnostic systems-based approach is helpful to unravel the wholistic genetic architecture that underlies phenotypes including metabolism. Homeostatic metabolite levels in the blood are the sum of the rates of importation from the environment, production and degradation in all of the tissues that contact blood [37] [38] [39] . Thus, it is important to include investigations of potential genetic mechanisms in all body tissues.
Notably, previous studies have demonstrated the effects of genetic interactions in tissues that seem irrelevant to the phenotypes under investigation [40] [41] [42] [43] . We propose that eQTLs affect metabolism by modulating the expression of genes that encode the protein components (i.e. enzymes, transcription factors, inhibitors, transporters, receptors etc.) of metabolism.
In conclusion, we have shown that blood metabolite-associated SNPs mark expression quantitative trait loci that affect the expression of proximal and distal genes in tissues that are relevant to the associated metabolites. The hundreds of novel eSNP-eGene-metabolite connections identified in this study are a useful resource for further empirical study of the genetic influences of the human metabolome.
Methods
Data sources
The 145 metabolite-associated Single Nucleotide Polymorphisms (SNPs) investigated in this study are the genome-wide significant hits from Shin et al 5 . Genomic positions of SNPs were obtained from the human hg19 genome build chromosome bed files downloaded from NCBI (See Data Availability). Gene synonyms and full names were obtained from NCBI's gene information dataset (ftp.ncbi.nih.gov:gene/DATA/GENE_INFO/Mammalia/Homo_sapiens.gene_info.gz). We used the GENCODE transcript model (See Data Availability) as reference for gene annotations, which is the same reference used in GTEx. All isoforms of a gene were collapsed into a single gene. The human genome used in this study is the hg19 (GRChr37) build of the human genome release 75 (See Data Availability).
Identification of SNP target genes
The CoDeS3D 24 pipeline was used to identify target genes of SNPs ( Supplementary  Figure 1 ). In summary, restricted fragments that harbor the SNPs were identified in the human genome. Chromatin interaction (Hi-C) libraries from eight cell lines (i.e. GM12878, HeLa, HMEC, HUVEC, IMR90, K562, KBM7 and NHEK; Supplementary  Table 1 ) 25 were then queried to identify gene fragments that are captured as spatially interacting with the SNP-containing fragments. The resulting spatial SNP-gene pairs were used to query GTEx V7 to identify eSNP-eGene pairs in 48 human tissues. eSNP-eGene-tissue associations with adjusted p values < 0.05 (FDR, Benjamini-Hochberg correction) were deemed significant.
